Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


1 Dev Med Child Neurol
3 Epilepsia
1 Epilepsy Res
8 Epileptic Disord
3 J Neurol
1 PLoS One
8 Seizure

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Dev Med Child Neurol

  1. WANG X, Ding Y, Zhou Y, Yu L, et al
    Prenatal diagnosis and intervention improve developmental outcomes and epilepsy prognosis in children with tuberous sclerosis complex.
    Dev Med Child Neurol. 2022 May 25. doi: 10.1111/dmcn.15265.
    PubMed         Abstract available


  2. MALONEY EM, Corcoran P, Costello DJ, O'Reilly EJ, et al
    Association between social deprivation and incidence of first seizures and epilepsy: a prospective population based cohort.
    Epilepsia. 2022 May 25. doi: 10.1111/epi.17313.
    PubMed         Abstract available

  3. MAKHALOVA J, Medina Villalon S, Wang H, Giusiano B, et al
    Virtual Epileptic Patient brain modeling: relationships with seizure onset and surgical outcome.
    Epilepsia. 2022 May 23. doi: 10.1111/epi.17310.
    PubMed         Abstract available

  4. BAKULA DM, Junger KW, Guilfoyle SM, Mara CA, et al
    Key Predictors of the Need for a Family-Focused Pediatric Epilepsy Adherence Intervention.
    Epilepsia. 2022 May 21. doi: 10.1111/epi.17302.
    PubMed         Abstract available

    Epilepsy Res

  5. SVENDSEN T, Brodtkorb E, Linge HL, Burns ML, et al
    Efficacy, tolerability and pharmacokinetic variability of brivaracetam in adults with difficult-to-treat epilepsy.
    Epilepsy Res. 2022;183:106946.
    PubMed         Abstract available

    Epileptic Disord

  6. NERI S, Mastroianni G, Gardella E, Aguglia U, et al
    Epilepsy in neurodegenerative diseases.
    Epileptic Disord. 2022;24:249-273.
    PubMed         Abstract available

  7. FOGED MT, Scherg M, Fabricius M, Beniczky S, et al
    Learn to interpret voltage maps: an atlas of topographies.
    Epileptic Disord. 2022;24:229-248.
    PubMed         Abstract available

  8. NOORAINE J, Raghavendra S
    Complexities of frontal eye field seizure semiology.
    Epileptic Disord. 2022;24:431-434.

  9. KVERNADZE A, Tatishvili N, Lomidze G, Tarkhnishvili N, et al
    Predictors of outcome among 31 children with infantile spasms syndrome.
    Epileptic Disord. 2022;24:359-372.
    PubMed         Abstract available

  10. ESPINO PH, Burneo JG
    Dacrystic seizures in MRI-negative patients.
    Epileptic Disord. 2022;24:427-430.

  11. KAESTNER E, Pedersen NP, Hu R, Vosoughi A, et al
    Electrical Wada for pre-surgical memory testing: a case report.
    Epileptic Disord. 2022;24:411-416.
    PubMed         Abstract available

  12. VLACHOU M, Skrimpas GA, Kural MA, Rackauskaite G, et al
    Electroclinical features and long-term therapeutic response in patients with typical absence seizures.
    Epileptic Disord. 2022;24:315-322.
    PubMed         Abstract available

  13. CARRILLO R, Cantillano C, Uribe-San-Martin R
    Post-ictal subtle ptosis ipsilateral to mesial temporal lobe sclerosis.
    Epileptic Disord. 2022;24:438-441.

    J Neurol

    Frontal lobe seizures: overview and update.
    J Neurol. 2022;269:3363-3371.
    PubMed         Abstract available

  15. GUERY D, Cousyn L, Navarro V, Picard G, et al
    Long-term evolution and prognostic factors of epilepsy in limbic encephalitis with LGI1 antibodies.
    J Neurol. 2022 May 20. pii: 10.1007/s00415-022-11162.
    PubMed         Abstract available

  16. BOESEN MS, Borresen ML, Christensen SK, Klein-Petersen AW, et al
    School performance and psychiatric comorbidity in juvenile absence epilepsy and juvenile myoclonic epilepsy: a Danish population-based cohort study.
    J Neurol. 2022 May 20. pii: 10.1007/s00415-022-11147.
    PubMed         Abstract available

    PLoS One

  17. LEITNER DF, Kanshin E, Askenazi M, Siu Y, et al
    Pilot study evaluating everolimus molecular mechanisms in tuberous sclerosis complex and focal cortical dysplasia.
    PLoS One. 2022;17:e0268597.
    PubMed         Abstract available


  18. CARROLL JH, Martin-McGill KJ, Cross JH, Hickson M, et al
    Core outcome set development for childhood epilepsy treated with ketogenic diet therapy: Results of a scoping review and parent interviews.
    Seizure. 2022;99:54-67.
    PubMed         Abstract available

  19. BOERO G, La Neve A, Pontrelli G
    Epilepsy with seizures induced by movement: A rare reflex epilepsy.
    Seizure. 2022;99:68-70.

  20. LU Q, Wang YY, Wang QH, Tang LN, et al
    Safety of inactivated COVID-19 vaccine in tuberous sclerosis complex patients with epilepsy treated with rapamycin.
    Seizure. 2022;99:71-74.
    PubMed         Abstract available

  21. TONG X, Deng Y, Liu L, Tang X, et al
    Clinical implementation of ketogenic diet in children with drug-resistant epilepsy: Advantages, disadvantages, and difficulties.
    Seizure. 2022;99:75-81.
    PubMed         Abstract available

  22. WANG Y, Xu J, Liu T, Chen F, et al
    Diagnostic value of high-frequency oscillations for the epileptogenic zone: A systematic review and meta-analysis.
    Seizure. 2022;99:82-90.
    PubMed         Abstract available

  23. LIANG X, Yu N, Zhang YF, Gu L, et al
    Corrigendum to 'Prognostic implications of persistent interictal epileptiform discharges on antiseizure medication withdrawal in patients with epilepsy in five-year remission [Seizure: European Journal of Epilepsy 94 (2022) 100-106].
    Seizure. 2022 May 22. pii: S1059-1311(22)00119.

  24. LYSTAD RP, McMaugh A, Herkes G, Badgery-Parker T, et al
    The impact of childhood epilepsy on academic performance: A population-based matched cohort study.
    Seizure. 2022;99:91-98.
    PubMed         Abstract available

  25. KIM HJ, Jeon JY, Kim HW, Lee SA, et al
    Validation of items on the NDDIE and PHQ-9 associated with suicidal ideation during suicidality screening in patients with epilepsy.
    Seizure. 2022;99:99-104.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Epilepsy is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.